Hyperuricemia led to the activation of hypoxia inducible factor-1 α (HIF-1 α ), and inhibition of HIF-1 α by YC-1 (a HIF-1 α inhibitor) prevented the increase of miR-295. Here, SETD2 is linked to hyperuricemia.